Literature DB >> 4186978

Rifamycin antibiotics in chronic purulent bronchitis.

K M Citron, J R May.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4186978     DOI: 10.1016/s0140-6736(69)90539-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.

Authors:  S Dixson; W Brumfitt; J M Hamilton-Miller
Journal:  Eur J Clin Microbiol       Date:  1985-02       Impact factor: 3.267

2.  Chemotherapy of bronchitis.

Authors: 
Journal:  Br Med J       Date:  1970-01-17

3.  Evidence that rifampicin can be used safely for non-tuberculous diseases.

Authors:  G Acocella; W Brumfitt; J M Hamilton-Miller
Journal:  Thorax       Date:  1980-10       Impact factor: 9.139

4.  Clinical uses and control of rifampicin and clindamycin.

Authors:  I Phillips
Journal:  J Clin Pathol       Date:  1971-07       Impact factor: 3.411

Review 5.  Rifampicin: a review.

Authors: 
Journal:  Drugs       Date:  1971       Impact factor: 9.546

Review 6.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

7.  Sensitivity of Haemophilus influenzae to antibiotics.

Authors:  J D Williams; J Andrews
Journal:  Br Med J       Date:  1974-01-26

8.  Antibiotics for exacerbations of chronic obstructive pulmonary disease.

Authors:  Daniela J Vollenweider; Anja Frei; Claudia A Steurer-Stey; Judith Garcia-Aymerich; Milo A Puhan
Journal:  Cochrane Database Syst Rev       Date:  2018-10-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.